Conquering Diseases

Study Of An Investigational Drug For Bile Duct Cancer Or Cholangiocarcinoma

Description

Seeking men or women living with cancer of the bile duct, also known as cholangiocarcinoma, who need to change therapies for a study of the safety and effectiveness of an investigational drug either on its own or in combination with other drugs.

Overview

We are studying whether an investigational drug taken alone or in combination with other drugs is safe and effective for bile duct cancer or cholangiocarcinoma that has progressed or for people who have become intolerant of the therapy usually given first.

What we're hoping for

To better understand whether the investigational drug works better when taken alone or in combination with other drugs for bile duct cancer or cholangiocarcinoma and whether characteristics of the tumor makes a difference.

Additional Information

ClinicalTrials.gov Identifier: NCT04175912

 Principal Investigator

Patan  Gultawatvichai, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989